(Q34123145)

31 July 2017

1 reference

title

Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis? (English)

1 reference

31 July 2017

0 references

Jean-Claude Souberbielle

series ordinal

object named as

Jean-Claude Souberbielle

1 reference

Charles Pierrot-Deseilligny

31 July 2017

series ordinal

object named as

Charles Pierrot-Deseilligny

0 references

author name string

Charles Pierrot-Deseilligny

series ordinal

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

31 July 2017

1 reference

31 July 2017

volume

133

1 reference

31 July 2017

issue

Pt 7

1 reference

31 July 2017

page(s)

1869-1888

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

31 July 2017

1 reference

Control of autoimmune diseases by the vitamin D endocrine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Teenage girls and elderly women living in northern Europe have low winter vitamin D status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Epidemiology of multiple sclerosis: from risk factors to prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Environmental risk factors for multiple sclerosis. Part I: The role of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Epstein-Barr virus in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D supplement consumption is required to achieve a minimal target 25-hydroxyvitamin D concentration of > or = 75 nmol/L in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Low vitamin D status despite abundant sun exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Effect of Vitamin D on falls: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Diagnosis and treatment of vitamin D deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D and multiple sclerosis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D: current status and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Immunomodulatory effects of Vitamin D in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Estimates of optimal vitamin D status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Evolutionary biology: geography and skin colour

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Three-phase model harmonizes estimates of the maximal suppression of parathyroid hormone by 25-hydroxyvitamin D in persons 65 years of age and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Environmental factors and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Modern concepts in the diagnosis and treatment of vitamin D deficiency and its clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Season of birth and not vitamin D receptor promoter polymorphisms is a risk factor for multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Migrant studies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

The causal cascade to multiple sclerosis: a model for MS pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Competitive protein-binding radioassay for 25-hydroxycholecalciferol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Environmental factors and their timing in adult-onset multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D3 distribution and status in the body

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Cigarette smoking and the progression of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

THE CURE OF INFANTILE RICKETS BY SUNLIGHT

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D: a D-Lightful health perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Novel tempeh (fermented soyabean) isoflavones inhibit in vivo angiogenesis in the chicken chorioallantoic membrane assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

The expanding genetic overlap between multiple sclerosis and type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

The evolution of human skin coloration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D: a candidate for the environmental effect in multiple sclerosis - observations from Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Geographic location and vitamin D synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Some contributions of the Department of Veterans Affairs to the epidemiology of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

UVB-induced conversion of 7-dehydrocholesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D status and nutrition in Europe and Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Regulation of cutaneous immunity by the environment: an important role for UV irradiation and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

TGF-beta and vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Cytokine profile in patients with multiple sclerosis following vitamin D supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D and autoimmune disease--implications for practice from the multiple sclerosis literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

A cross-sectional study of bone health in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Time of birth, residential solar radiation and age at onset of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

The vitamin D receptor is necessary for 1alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

New hypotheses on sunlight and the geographic variability of multiple sclerosis prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Parental smoking at home and the risk of childhood-onset multiple sclerosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Global vitamin D status and determinants of hypovitaminosis D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D treatment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Efficacy of food fortification on serum 25-hydroxyvitamin D concentrations: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

The epidemiology of multiple sclerosis in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Multiple sclerosis and the major histocompatibility complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

HLA-DRB1 and month of birth in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Association of infectious mononucleosis with multiple sclerosis. A population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D and the skin: an ancient friend, revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

New insights into the role of vitamin D and calcium in osteoporosis management: an expert roundtable discussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Multiple sclerosis: light at the end of the tunnel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Multiple sclerosis, osteoporosis, and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D as an immune modulator in multiple sclerosis, a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D: bone and beyond, rationale and recommendations for supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Seasonal fluctuation of multiple sclerosis births in Sardinia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Latitudinal variation in incidence and type of first central nervous system demyelinating events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D status as a determinant of peak bone mass in young Finnish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Multiple sclerosis and vitamin D: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

21 January 2018

Prehospital thrombolysis

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

The role of vitamin D in the prevention of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

What is the optimal vitamin D status for health?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D controls T cell antigen receptor signaling and activation of human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Regional variations in the prevalence of multiple sclerosis in French farmers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D deficiency and risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Timing of birth and risk of multiple sclerosis: population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D: in the evolution of human skin colour

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Selective association of multiple sclerosis with infectious mononucleosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Vitamin D in preventive medicine: are we ignoring the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: The effect of UVB dose and skin color

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

SPECIFIC HIGH-AFFINITY RECEPTORS FOR 1,25-DIHYDROXYVITAMIN D3IN HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS: PRESENCE IN MONOCYTES AND INDUCTION IN T LYMPHOCYTES FOLLOWING ACTIVATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Serum vitamin D concentrations among elderly people in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

Editorial regarding “Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis,” by Beretich and Beretich

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ147

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWQ147

1 reference

release_74m2bvfienbbfhj4vn5oqk3dgm

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/74m2bvfienbbfhj4vn5oqk3dgm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference